1
|
Papalia G, Barbuto S, Campus A, Vischini G. Double glomerulopathies or two-faced janus? A challenging case in the COVID-19 era. J Nephrol 2023; 36:225-8. [PMID: 35666373 DOI: 10.1007/s40620-022-01351-8] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/20/2022] [Accepted: 05/10/2022] [Indexed: 02/07/2023]
Abstract
SARS-CoV-2 very often causes kidney involvement through various mechanisms including: acute tubular injury, virus cell invasion, vascular damage due to hypercoagulability and finally dysregulation of the immune system. Even though there are no pathognomonic morphologic features that can rule out or confirm direct damage by SARS-CoV-2, the latest literature suggests that there may be some association. SARS-CoV-2 infection represents a poor prognostic factor, regardless of pulmonary involvement. We report a challenging case with complex renal biopsy findings suggestive of collapsing glomerulopathy and focal proliferative IgA-dominant glomerulonephritis in a patient affected by active hepatitis C virus (HCV), SARS-CoV-2 infection and personal history of cocaine abuse.
Collapse
|
2
|
Kesiena O, Papadopoulos P, Amakye D, Hama E, Mackay R. COVID-19 associated collapsing glomerulopathy presenting as acute kidney injury on chronic kidney disease: a case report and review of the literature. CEN Case Rep 2022; 11:273-277. [PMID: 34825347 PMCID: PMC8616717 DOI: 10.1007/s13730-021-00667-x] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/26/2021] [Accepted: 11/17/2021] [Indexed: 02/06/2023] Open
Abstract
Traditionally collapsing glomerulopathy (CG) is associated with medications, autoimmune disease, viral infection and the APOL1 gene variant seen in blacks/African Americans. Most reported cases of acute kidney injury (AKI) in COVID-19 infected individuals have been in individuals without prior CKD. In this report, we present a 49-year-old African American female with a past medical history of chronic kidney disease (CKD) stage 4, hypertension, type 2 diabetes mellitus, recent COVID-19 infection, and a repeat positive blood test for COVID-19 more than 21 days after the initial result, who presented with an AKI on CKD. Renal biopsy revealed a collapsing glomerulopathy. She was started on hemodialysis and did not receive immunosuppressive therapy due to the advanced scaring seen on the renal biopsy. Concerning the pathophysiology of COVID-19-associated CG, researchers have postulated different mechanisms such as a direct cytopathic effect of the virus on podocytes, immune dysregulation, and fluid imbalance. This is one of a few cases of AKI on CKD due to CG related to COVID-19. The mechanism of CG was, however, unclear. Currently, there is no specific interventions to prevent the development of CG in patients with COVID-19 infection. Further studies should investigate measures to prevent the development of CG.
Collapse
Affiliation(s)
- Onoriode Kesiena
- Department of Internal Medicine, Piedmont Athens Regional Medical Center, 1199 Prince Avenue, Athens, GA, 30606, USA.
| | - Pia Papadopoulos
- Department of Internal Medicine, Piedmont Athens Regional Medical Center, 1199 Prince Avenue, Athens, GA, 30606, USA
| | - Dominic Amakye
- Department of Internal Medicine, Piedmont Athens Regional Medical Center, 1199 Prince Avenue, Athens, GA, 30606, USA
| | - Eunice Hama
- Department of Internal Medicine, Piedmont Athens Regional Medical Center, 1199 Prince Avenue, Athens, GA, 30606, USA
| | - Rene Mackay
- Department of Nephrology, Piedmont Athens Regional Medical Center, Athens, GA, USA
| |
Collapse
|
3
|
Alkelai A, Greenbaum L, Heinzen EL, Baugh EH, Teitelbaum A, Zhu X, Strous RD, Tatarskyy P, Zai CC, Tiwari AK, Tampakeras M, Freeman N, Müller DJ, Voineskos AN, Lieberman JA, Delaney SL, Meltzer HY, Remington G, Kennedy JL, Pulver AE, Peabody EP, Levy DL, Lerer B. New insights into tardive dyskinesia genetics: Implementation of whole-exome sequencing approach. Prog Neuropsychopharmacol Biol Psychiatry 2019; 94:109659. [PMID: 31153890 DOI: 10.1016/j.pnpbp.2019.109659] [Citation(s) in RCA: 7] [Impact Index Per Article: 1.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 04/02/2019] [Revised: 05/23/2019] [Accepted: 05/24/2019] [Indexed: 02/07/2023]
Abstract
Tardive dyskinesia (TD) is an adverse movement disorder induced by chronic treatment with antipsychotics drugs. The contribution of common genetic variants to TD susceptibility has been investigated in recent years, but with limited success. The aim of the current study was to investigate the potential contribution of rare variants to TD vulnerability. In order to identify TD risk genes, we performed whole-exome sequencing (WES) and gene-based collapsing analysis focusing on rare (allele frequency < 1%) and putatively deleterious variants (qualifying variants). 82 Jewish schizophrenia patients chronically treated with antipsychotics were included and classified as having severe TD or lack of any abnormal movements based on a rigorous definition of the TD phenotype. First, we performed a case-control, exome-wide collapsing analysis comparing 39 schizophrenia patients with severe TD to 3118 unrelated population controls. Then, we checked the potential top candidate genes among 43 patients without any TD manifestations. All the genes that were found to harbor one or more qualifying variants in patients without any TD features were excluded from the final list of candidate genes. Only one gene, regulating synaptic membrane exocytosis 2 (RIMS2), showed significant enrichment of qualifying variants in TD patients compared with unrelated population controls after correcting for multiple testing (Fisher's exact test p = 5.32E-08, logistic regression p = 2.50E-08). Enrichment was caused by a single variant (rs567070433) due to a frameshift in an alternative transcript of RIMS2. None of the TD negative patients had qualifying variants in this gene. In a validation cohort of 140 schizophrenia patients assessed for TD, the variant was also not detected in any individual. Some potentially suggestive TD genes were detected in the TD cohort and warrant follow-up in future studies. No significant enrichment in previously reported TD candidate genes was identified. To the best of our knowledge, this is the first WES study of TD, demonstrating the potential role of rare loss-of-function variant enrichment in this pharmacogenetic phenotype.
Collapse
Affiliation(s)
- Anna Alkelai
- Institute for Genomic Medicine, Columbia University Medical Center, New York, USA.
| | - Lior Greenbaum
- The Danek Gertner Institute of Human Genetics, Sheba Medical Center, Tel Hashomer, Israel; The Joseph Sagol Neuroscience Center, Sheba Medical Center, Tel Hashomer, Israel; Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel
| | - Erin L Heinzen
- Institute for Genomic Medicine, Columbia University Medical Center, New York, USA
| | - Evan H Baugh
- Institute for Genomic Medicine, Columbia University Medical Center, New York, USA
| | - Alexander Teitelbaum
- Jerusalem Mental Health Center, Kfar Shaul Psychiatric Hospital, Hebrew University-Hadassah School of Medicine, Jerusalem, Israel
| | - Xiaolin Zhu
- Institute for Genomic Medicine, Columbia University Medical Center, New York, USA
| | - Rael D Strous
- Maayenei Hayeshua Medical Center, Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel
| | - Pavel Tatarskyy
- Biological Psychiatry Laboratory, Department of Psychiatry, Hadassah-Hebrew University Medical Center, Jerusalem, Israel
| | - Clement C Zai
- Tanenbaum Centre for Pharmacogenetics, Campbell Family Mental Health Research Institute, Centre for Addiction and Mental Health, Toronto, Canada; Department of Psychiatry, University of Toronto, Toronto, Canada; Institute of Medical Science, University of Toronto, Toronto, Canada; Laboratory Medicine and Pathobiology, University of Toronto, Toronto, Canada
| | - Arun K Tiwari
- Tanenbaum Centre for Pharmacogenetics, Campbell Family Mental Health Research Institute, Centre for Addiction and Mental Health, Toronto, Canada; Department of Psychiatry, University of Toronto, Toronto, Canada
| | - Maria Tampakeras
- Tanenbaum Centre for Pharmacogenetics, Campbell Family Mental Health Research Institute, Centre for Addiction and Mental Health, Toronto, Canada
| | - Natalie Freeman
- Tanenbaum Centre for Pharmacogenetics, Campbell Family Mental Health Research Institute, Centre for Addiction and Mental Health, Toronto, Canada
| | - Daniel J Müller
- Tanenbaum Centre for Pharmacogenetics, Campbell Family Mental Health Research Institute, Centre for Addiction and Mental Health, Toronto, Canada; Department of Psychiatry, University of Toronto, Toronto, Canada; Institute of Medical Science, University of Toronto, Toronto, Canada
| | - Aristotle N Voineskos
- Tanenbaum Centre for Pharmacogenetics, Campbell Family Mental Health Research Institute, Centre for Addiction and Mental Health, Toronto, Canada; Department of Psychiatry, University of Toronto, Toronto, Canada; Institute of Medical Science, University of Toronto, Toronto, Canada
| | - Jeffrey A Lieberman
- Columbia University, New York State Psychiatric Institute, New York City, NY, USA
| | - Shannon L Delaney
- Columbia University, New York State Psychiatric Institute, New York City, NY, USA
| | - Herbert Y Meltzer
- Psychiatry and Behavioral Sciences, Pharmacology and Physiology, Chemistry of Life Processes Institute, Northwestern University Feinberg School of Medicine, Chicago, IL, USA
| | - Gary Remington
- Tanenbaum Centre for Pharmacogenetics, Campbell Family Mental Health Research Institute, Centre for Addiction and Mental Health, Toronto, Canada; Department of Psychiatry, University of Toronto, Toronto, Canada; Institute of Medical Science, University of Toronto, Toronto, Canada
| | - James L Kennedy
- Tanenbaum Centre for Pharmacogenetics, Campbell Family Mental Health Research Institute, Centre for Addiction and Mental Health, Toronto, Canada; Department of Psychiatry, University of Toronto, Toronto, Canada; Institute of Medical Science, University of Toronto, Toronto, Canada
| | - Ann E Pulver
- Department of Psychiatry and Behavioral Sciences, Johns Hopkins University School of Medicine, Baltimore, MD, USA
| | - Emma P Peabody
- Psychology Research Laboratory, McLean Hospital, Harvard Medical School, Belmont, MA, USA
| | - Deborah L Levy
- Psychology Research Laboratory, McLean Hospital, Harvard Medical School, Belmont, MA, USA
| | - Bernard Lerer
- Biological Psychiatry Laboratory, Department of Psychiatry, Hadassah-Hebrew University Medical Center, Jerusalem, Israel
| |
Collapse
|
4
|
Grèze C, Garrouste C, Kemeny JL, Philipponnet C, Aniort J, Heng AÉ. [ Collapsing focal segmental glomerulosclerosis induced by cytomegalovirus: A case report]. Nephrol Ther 2017; 14:50-53. [PMID: 29191574 DOI: 10.1016/j.nephro.2017.06.002] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/16/2017] [Revised: 04/26/2017] [Accepted: 06/01/2017] [Indexed: 10/18/2022]
Abstract
Focal segmental glomerulosclerosis (FSGS) is a common cause of nephrotic syndrome in child and adult. The collapsing forms are of poor renal prognosis and are usually secondary to viral infections with, first and foremost, the human immunodeficiency virus. Among other viral etiologies, cytomegalovirus (CMV) is an uncommon cause. We report a case of a 32years-old patient with collapsing focal segmental glomerulosclerosis induced by cytomegalovirus with initial acute renal failure and proteinuria at 12.4g/24h. The treatment associated ganciclovir during 7days followed by valganciclovir during 14days and steroids at 1mg/kg/day. Renal function improved and proteinuria decreased with this treatment. Proteinuria increase again 3weeks after valganciclovir discontinuation while CMV Polymerase chain reaction (PCR) was positive. Therefore, valganciclovir has been resumed allowing renal function normalization and decrease in proteinuria to 4g/24h after negative CMVPCR assay after 15weeks. Anti-CMV therapy combined with steroids seems to provide a renal response in case of FSGS induced by CMV even if long-term prognosis stays uncertain.
Collapse
Affiliation(s)
- Clarisse Grèze
- Service de néphrologie, CHU Gabriel-Montpied, 58, rue Montalembert, BP 69, 63000 Clermont-Ferrand cedex, France.
| | - Cyril Garrouste
- Service de néphrologie, CHU Gabriel-Montpied, 58, rue Montalembert, BP 69, 63000 Clermont-Ferrand cedex, France
| | - Jean-Louis Kemeny
- Laboratoire d'anatomopathologie, CHU Gabriel-Montpied, 58, rue Montalembert, BP 69, 63000 Clermont-Ferrand cedex, France
| | - Carole Philipponnet
- Service de néphrologie, CHU Gabriel-Montpied, 58, rue Montalembert, BP 69, 63000 Clermont-Ferrand cedex, France
| | - Julien Aniort
- Service de néphrologie, CHU Gabriel-Montpied, 58, rue Montalembert, BP 69, 63000 Clermont-Ferrand cedex, France
| | - Anne-Élisabeth Heng
- Service de néphrologie, CHU Gabriel-Montpied, 58, rue Montalembert, BP 69, 63000 Clermont-Ferrand cedex, France
| |
Collapse
|
5
|
Roos S. A Characterization of Codimension One Collapse Under Bounded Curvature and Diameter. J Geom Anal 2017; 28:2707-2724. [PMID: 30839898 PMCID: PMC6294179 DOI: 10.1007/s12220-017-9930-0] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Grants] [Track Full Text] [Figures] [Subscribe] [Scholar Register] [Received: 04/06/2017] [Indexed: 06/09/2023]
Abstract
Let M ( n , D ) be the space of closed n-dimensional Riemannian manifolds (M, g) with diam ( M ) ≤ D and | sec M | ≤ 1 . In this paper we consider sequences ( M i , g i ) in M ( n , D ) converging in the Gromov-Hausdorff topology to a compact metric space Y. We show, on the one hand, that the limit space of this sequence has at most codimension one if there is a positive number r such that the quotient vol ( B r M i ( x ) ) inj M i ( x ) can be uniformly bounded from below by a positive constant C(n, r, Y) for all points x ∈ M i . On the other hand, we show that if the limit space has at most codimension one then for all positive r there is a positive constant C(n, r, Y) bounding the quotient vol ( B r M i ( x ) ) inj M i ( x ) uniformly from below for all x ∈ M i . As a conclusion, we derive a uniform lower bound on the volume and a bound on the essential supremum of the sectional curvature for the closure of the space consisting of all manifolds in M ( n , D ) with C ≤ vol ( M ) inj ( M ) .
Collapse
Affiliation(s)
- Saskia Roos
- Max-Planck-Institut für Mathematik, Vivatsgasse 7, 53111 Bonn, Germany
| |
Collapse
|
6
|
Bienvenu F, Akçay E, Legendre S, McCandlish DM. The genealogical decomposition of a matrix population model with applications to the aggregation of stages. Theor Popul Biol 2017; 115:69-80. [PMID: 28476403 DOI: 10.1016/j.tpb.2017.04.002] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/04/2016] [Revised: 04/19/2017] [Accepted: 04/26/2017] [Indexed: 10/19/2022]
Abstract
Matrix projection models are a central tool in many areas of population biology. In most applications, one starts from the projection matrix to quantify the asymptotic growth rate of the population (the dominant eigenvalue), the stable stage distribution, and the reproductive values (the dominant right and left eigenvectors, respectively). Any primitive projection matrix also has an associated ergodic Markov chain that contains information about the genealogy of the population. In this paper, we show that these facts can be used to specify any matrix population model as a triple consisting of the ergodic Markov matrix, the dominant eigenvalue and one of the corresponding eigenvectors. This decomposition of the projection matrix separates properties associated with lineages from those associated with individuals. It also clarifies the relationships between many quantities commonly used to describe such models, including the relationship between eigenvalue sensitivities and elasticities. We illustrate the utility of such a decomposition by introducing a new method for aggregating classes in a matrix population model to produce a simpler model with a smaller number of classes. Unlike the standard method, our method has the advantage of preserving reproductive values and elasticities. It also has conceptually satisfying properties such as commuting with changes of units.
Collapse
Affiliation(s)
- François Bienvenu
- Institut de Biologie de l'Ecole Normale Supérieure (IBENS), CNRS, INSERM, Ecole Normale Supérieure, PSL Research University, F-75005 Paris, France; University of Pennsylvania Biology Department, Philadelphia, PA 19104, USA; Center for Interdisciplinary Research in Biology (CIRB), Collège de France, CNRS, INSERM, PSL Research University, F-75005 Paris, France.
| | - Erol Akçay
- University of Pennsylvania Biology Department, Philadelphia, PA 19104, USA
| | - Stéphane Legendre
- Institut de Biologie de l'Ecole Normale Supérieure (IBENS), CNRS, INSERM, Ecole Normale Supérieure, PSL Research University, F-75005 Paris, France
| | - David M McCandlish
- University of Pennsylvania Biology Department, Philadelphia, PA 19104, USA; Simons Center for Quantitative Biology, Cold Spring Harbor Laboratory, Cold Spring Harbor, NY 11724, USA.
| |
Collapse
|
7
|
Laessker AN, Hardarsson T, Forsberg AS, Mukaida T, Holmes PV. Appendix G: Vitrification of Blastocysts Using VitriBlast TM and ThermoBlast TM: Nidacon. Methods Mol Biol 2017; 1568:355-365. [PMID: 28421511 DOI: 10.1007/978-1-4939-6828-2_27] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 06/07/2023]
Abstract
This appendix describes the vitrification of blastocysts using VitriBlast™ (VBK) and ThermoBlast™ (TBK) from Nidacon, Mölndal, Sweden. The technique used and the reason for not including DMSO in the medium at the production stage, but including it separately in the kit, and the importance of collapsing the blastocyst prior to vitrification will be explained and described.
Collapse
Affiliation(s)
- Anna Niläng Laessker
- Product Development, Nidacon International AB, Flöjelbergsgatan 16b, 43137, Mölndal, Sweden.
| | | | - Ann-Sofie Forsberg
- Product Development, Nidacon International AB, Flöjelbergsgatan 16b, 43137, Mölndal, Sweden
| | - Tetsunori Mukaida
- Hiroshima Hart Clinic, 5-7-10 Ohtemachi Nakaku, Hiroshima, 7300051, Japan
| | - Paul V Holmes
- Product Development, Nidacon International AB, Flöjelbergsgatan 16b, 43137, Mölndal, Sweden
| |
Collapse
|
8
|
Mesa-Eguiagaray I, Böhning D, McLean C, Griffiths P, Bridges J, Pickering RM. Inter-rater reliability of the QuIS as an assessment of the quality of staff-inpatient interactions. BMC Med Res Methodol 2016; 16:171. [PMID: 27927178 PMCID: PMC5142422 DOI: 10.1186/s12874-016-0266-4] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/01/2016] [Accepted: 11/16/2016] [Indexed: 11/10/2022] Open
Abstract
BACKGROUND Recent studies of the quality of in-hospital care have used the Quality of Interaction Schedule (QuIS) to rate interactions observed between staff and inpatients in a variety of ward conditions. The QuIS was developed and evaluated in nursing and residential care. We set out to develop methodology for summarising information from inter-rater reliability studies of the QuIS in the acute hospital setting. METHODS Staff-inpatient interactions were rated by trained staff observing care delivered during two-hour observation periods. Anticipating the possibility of the quality of care varying depending on ward conditions, we selected wards and times of day to reflect the variety of daytime care delivered to patients. We estimated inter-rater reliability using weighted kappa, κ w , combined over observation periods to produce an overall, summary estimate, [Formula: see text]. Weighting schemes putting different emphasis on the severity of misclassification between QuIS categories were compared, as were different methods of combining observation period specific estimates. RESULTS Estimated [Formula: see text] did not vary greatly depending on the weighting scheme employed, but we found simple averaging of estimates across observation periods to produce a higher value of inter-rater reliability due to over-weighting observation periods with fewest interactions. CONCLUSIONS We recommend that researchers evaluating the inter-rater reliability of the QuIS by observing staff-inpatient interactions during observation periods representing the variety of ward conditions in which care takes place, should summarise inter-rater reliability by κ w , weighted according to our scheme A4. Observation period specific estimates should be combined into an overall, single summary statistic [Formula: see text], using a random effects approach, with [Formula: see text], to be interpreted as the mean of the distribution of κ w across the variety of ward conditions. We draw attention to issues in the analysis and interpretation of inter-rater reliability studies incorporating distinct phases of data collection that may generalise more widely.
Collapse
Affiliation(s)
- Ines Mesa-Eguiagaray
- Medical Statistics Group, Faculty of Medicine, Southampton General Hospital, Mailpoint 805, Level B, South Academic Block, Southampton, SO16 6YD, UK
| | - Dankmar Böhning
- Southampton Statistical Sciences Research Institute & Mathematical Sciences, University of Southampton, Southampton, UK
| | - Chris McLean
- Faculty of Health Sciences, University of Southampton, Southampton, UK
| | - Peter Griffiths
- Faculty of Health Sciences, University of Southampton, Southampton, UK
| | - Jackie Bridges
- Faculty of Health Sciences, University of Southampton, Southampton, UK
| | - Ruth M Pickering
- Medical Statistics Group, Faculty of Medicine, Southampton General Hospital, Mailpoint 805, Level B, South Academic Block, Southampton, SO16 6YD, UK.
| |
Collapse
|
9
|
Gala A, Ferrières A, Assou S, Monforte M, Bringer-Deutsch S, Vintejoux E, Vincens C, Brunet C, Hamamah S. [Effects of artificial shrinkage prior to vitrification in a closed system: a randomized controlled trial]. ACTA ACUST UNITED AC 2014; 42:772-8. [PMID: 25442824 DOI: 10.1016/j.gyobfe.2014.09.006] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/24/2014] [Accepted: 09/05/2014] [Indexed: 01/10/2023]
Abstract
OBJECTIVE To evaluate the effect of induced blastocoele shrinkage before vitrification in a closed carrier device. PATIENTS AND METHODS Prior to vitrification, blastocyst cavity was artificially shrinked by laser pulse or not treated according to a 2:1 randomized procedure. A total of 185 warming cycles from April 2011 to March 2013 have been analyzed. Clinical pregnancy rate and survival rate were compared between the two groups. The mean (±SD) women age was 33.5±5.7 years for both groups. RESULTS The pregnancy rate in the group with artificial reduction of the cavity was higher ([32/67] 47.7%) than in the control group but not significantly ([43/113] 38%). The survival rate in the artificial shrinkage group was significantly higher compared with the control group : 99% (102/103) and 91.8% (168/183) respectively (P=0.01). DISCUSSION AND CONCLUSION This study reveals that artificial shrinkage of blastocoelic cavity by laser pulse before vitrification in a closed carrier device improves survival rate after warming.
Collapse
Affiliation(s)
- A Gala
- Institut de recherche en biothérapie, hôpital Saint-Éloi, CHU de Montpellier, 34000 Montpellier, France; U1040, Inserm, 34000 Montpellier, France; UFR de médecine, université Montpellier-1, 34000 Montpellier, France; Service de gynécologie-obstétrique, hôpital Arnaud-de-Villeneuve, CHU de Montpellier, 34295 Montpellier cedex 5, France
| | - A Ferrières
- Institut de recherche en biothérapie, hôpital Saint-Éloi, CHU de Montpellier, 34000 Montpellier, France; U1040, Inserm, 34000 Montpellier, France; Service de gynécologie-obstétrique, hôpital Arnaud-de-Villeneuve, CHU de Montpellier, 34295 Montpellier cedex 5, France
| | - S Assou
- Institut de recherche en biothérapie, hôpital Saint-Éloi, CHU de Montpellier, 34000 Montpellier, France; U1040, Inserm, 34000 Montpellier, France; UFR de médecine, université Montpellier-1, 34000 Montpellier, France
| | - M Monforte
- Service de gynécologie-obstétrique, hôpital Arnaud-de-Villeneuve, CHU de Montpellier, 34295 Montpellier cedex 5, France
| | - S Bringer-Deutsch
- Service de gynécologie-obstétrique, hôpital Arnaud-de-Villeneuve, CHU de Montpellier, 34295 Montpellier cedex 5, France
| | - E Vintejoux
- Service de gynécologie-obstétrique, hôpital Arnaud-de-Villeneuve, CHU de Montpellier, 34295 Montpellier cedex 5, France
| | - C Vincens
- Service de gynécologie-obstétrique, hôpital Arnaud-de-Villeneuve, CHU de Montpellier, 34295 Montpellier cedex 5, France
| | - C Brunet
- Service de gynécologie-obstétrique, hôpital Arnaud-de-Villeneuve, CHU de Montpellier, 34295 Montpellier cedex 5, France
| | - S Hamamah
- Institut de recherche en biothérapie, hôpital Saint-Éloi, CHU de Montpellier, 34000 Montpellier, France; U1040, Inserm, 34000 Montpellier, France; UFR de médecine, université Montpellier-1, 34000 Montpellier, France; Service de gynécologie-obstétrique, hôpital Arnaud-de-Villeneuve, CHU de Montpellier, 34295 Montpellier cedex 5, France.
| |
Collapse
|
10
|
Ahuja A, Gupta R, Sharma A, Bagga A, Bhowmik DM, Agarwal SK, Dinda AK. Idiopathic collapsing glomerulopathy: A clinicopathologic analysis of 30 cases. Indian J Nephrol 2014; 24:239-42. [PMID: 25097337 PMCID: PMC4119337 DOI: 10.4103/0971-4065.133009] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/10/2023] Open
Abstract
Collapsing glomerulopathy (CG) is a distinct clinicopathologic entity associated with various infections, medications and acute ischemia. There have been few scattered reports of CG from India. This study aimed at evaluating the clinicopathologic features of idiopathic CG in Indian patients with comparison between adult-onset and childhood CG. This study included all cases of idiopathic CG diagnosed over a period of 4 years (2006-2009). Appropriate clinical details and laboratory findings were retrieved. Renal biopsies were reviewed and detailed pathologic features assessed. Statistical analysis was performed to compare various features between adult-onset and childhood CG. Over these 4 years, 30 cases of idiopathic CG were diagnosed. Of these, 11 were children. Childhood CG cases had longer duration of symptoms and lower serum urea and creatinine levels compared with adult patients. In renal histology, tubular atrophy and interstitial fibrosis was frequent in our cases. Pediatric cases of CG showed a higher proportion of segmental glomerulosclerosis. On clinical follow-up, nine of the 30 patients progressed to end-stage renal disease and these included two pediatric patients. Idiopathic CG is a significant cause of renal dysfunction in both pediatric and adult patients. Childhood and adult-onset CG differ in few clinicopathologic features. Early and accurate diagnosis of CG is imperative for appropriate management of these patients.
Collapse
Affiliation(s)
- A Ahuja
- Department of Pathology, All India Institute of Medical Sciences, New Delhi, India
| | - R Gupta
- Department of Pathology, All India Institute of Medical Sciences, New Delhi, India
| | - A Sharma
- Department of Pathology, All India Institute of Medical Sciences, New Delhi, India
| | - A Bagga
- Department of Paediatrics, All India Institute of Medical Sciences, New Delhi, India
| | - D M Bhowmik
- Department of Nephrology, All India Institute of Medical Sciences, New Delhi, India
| | - S K Agarwal
- Department of Nephrology, All India Institute of Medical Sciences, New Delhi, India
| | - A K Dinda
- Department of Pathology, All India Institute of Medical Sciences, New Delhi, India
| |
Collapse
|
11
|
Abstract
Collapsing focal segmental glomerulosclerosis (cFSGS), also known as collapsing glomerulopathy (CG) is of considerable interest for a variety of reasons. Its incidence is on the rise, and in many parts of the world, it has emerged as one of the leading causes of end-stage renal disease (ESRD). There is currently no specific treatment and the response to standard immunotherapeutic agents is poor. Majority of the cases have been reported from the western countries, but the lesion is also being increasingly recognized in the tropical regions. It is imperative to increase the awareness of the lesion among the pathologists and the nephrologists from the developing countries for its accurate diagnosis and appropriate prognostication.
Collapse
Affiliation(s)
- Muhammed Mubarak
- Histopathology Department, Sindh Institute of Urology and Transplantation, Karachi, Pakistan
| |
Collapse
|